Examples
| Generic Name | Brand Name |
|---|
| rasagiline mesylate | Azilect |
| selegiline hydrochloride | Eldepryl, Emsam, Zelapar |
How It Works
Monoamine oxidase inhibitors (MAOIs)
prolong the effects of
dopamine in the brain by preventing its breakdown.
They also may prevent the removal of dopamine between nerve endings and enhance
release of dopamine from nerve cells. Rasagiline and selegiline are selective
monoamine oxidase (MAO-B) inhibitors.
Why It Is Used
MAO-B inhibitors may be used in the
early stages of
Parkinson's disease to treat very mild symptoms (such
as resting tremor) and delay the need for levodopa. However, they have minimal
effects when used alone, and better medications are available for this
purpose.
In people with advanced Parkinson's disease who are
taking levodopa, rasagiline or selegiline may be added to levodopa treatment to
reduce
motor fluctuations, increase the time of effect of the levodopa, and decrease
the amount of levodopa needed to control symptoms.
How Well It Works
In the early stages of Parkinson's
disease MAO-B inhibitors may improve symptoms and can delay the need for
levodopa. However, the benefits are considered modest.1
When used with levodopa in people with advanced
disease, rasagiline or selegiline may reduce motor fluctuations and increase
the length of “on” periods (times when medication is able to control
symptoms).2
Side Effects
When rasagiline or selegiline is used
alone, it causes few side effects in the doses that are used to treat
Parkinson's disease. These medicines can cause nausea, insomnia, and
occasionally confusion and hallucinations (seeing or hearing things that aren't
really there). Insomnia can be avoided by taking the last dose by midday so
that its stimulant effect will have declined before bedtime. Most people
tolerate MAO-B inhibitors fairly well.
Increased confusion and
other cognitive side effects are more likely to occur when MAO-B inhibitors are
used in combination with levodopa, especially in older people. Rasagiline and
selegiline also can cause frequent falls and should not be given to older
people who have orthostatic hypotension (low blood pressure when a person
stands up).
Certain risk-taking behavior, like uncontrollable
gambling and shopping, has been linked to medicines used to treat Parkinson's
disease. It seems that these behaviors may occur more often in patients taking
MAO-B inhibitors in addition to levodopa.
It may be dangerous to
take MAO-B inhibitors with antidepressants, including both selective serotonin
reuptake inhibitors (SSRIs, such as fluoxetine [Prozac] or sertraline [Zoloft])
and tricyclic antidepressants (such as amitriptyline or protriptyline
[Vivactil]).
Unlike other drugs in the
monoamine oxidase inhibitor (MAOI) class, rasagiline and selegiline are not
thought to cause high blood pressure when taken in combination with alcohol
(wine, beer, or sherry) or certain foods, including cheddar and aged cheeses,
avocados, bananas, liver, miso, pickled herring, and yeast extract. However, if
you experience a severe headache or chest pain while taking rasagiline or
selegiline, you should seek medical care immediately.
See Drug
Reference for a full list of side effects. (Drug Reference is not available in
all systems.)
What To Think About
MAO-B inhibitors have a mild
effect on the relief of Parkinson's disease symptoms when used alone. A greater
effect is seen when they are used in combination with levodopa.
Experts continue to debate whether rasagiline and selegiline may protect
dopamine-producing nerves in the brain and slow the progression of the disease.
Although some studies suggest that rasagiline and selegiline may help to slow
the progression of Parkinson's disease, they are currently being used only to
treat symptoms of the disease.
Complete the new medication information form (PDF)
(What is a PDF document?) to help you understand this medication.